By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioCardia, Inc. 

384 Oyster Point Boulevard, #4

South San Francisco  California  94080  U.S.A.
Phone: 650-624-0120 Fax: 650-624-0125


SEARCH JOBS


Industry
Biotechnology






Company News
BioCardia Release: RECARDIO Clinical Trial Doses First Patient 5/7/2014 10:50:15 AM
BioCardia Receives CE Mark For Morph AccessPro™ Steerable Introducer 3/17/2014 7:12:25 AM
BioCardia Receives CE Mark For New Helix™ Transendocardial Delivery Catheter 1/10/2014 8:17:21 AM
BioCardia Release: Phase 2 TAC-HFT Trial Shows Excellent Safety Profile, Suggests Efficacy, For Transendocardial Delivery Of Two Types Of Autologous Cells For Ischemic Heart Failure 11/18/2013 9:49:44 AM
Company Profile for BioCardia 3/8/2013 9:03:13 AM
Positive Results From BioCardia's Helical Infusion System Phase 1/2 Trial on Ischemic Cardiomyopathy 11/7/2012 7:38:41 AM
BioCardia and Juventas Therapeutics, Inc. Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure 3/15/2012 6:20:34 AM
BioCardia Says Morph AccessPro Receives FDA Clearance 5/4/2009 7:02:34 AM
Thoratec (THOR) Corporation Announces Equity Investment In Emerging Heart Failure Technology10/19/2005 5:10:38 PM
//-->